Notably, high levels of ARL4C methylation were significantly correlated with improved overall survival in patients with THYM, UCEC, UVM, CHOL, and brain lower-grade glioma (LGG), indicating that ARL4C methylation may serve as a protective factor in these individuals. This evidence concerns the gene ARL4C and thymoma.